Targeting the STAT3 oncogenic pathway: Cancer immunotherapy and drug repurposing
Author:
Publisher
Elsevier BV
Subject
Pharmacology,General Medicine
Reference174 articles.
1. Tumor immune microenvironment (TIME) to enhance antitumor immunity;Rajbhandary;Eur. J. Med. Res.,2023
2. Overcoming barriers to effective immunotherapy: MDSCs, TAMs, and Tregs as mediators of the immunosuppressive microenvironment in head and neck cancer;Davis;Oral. Oncol.,2016
3. The future of cancer immunotherapy: DNA vaccines leading the way;Pandya;Med. Oncol.,2023
4. Advances in landscape and related therapeutic targets of the prostate tumor microenvironment;Li;Acta Biochim. Et. Biophys. Sin.,2023
5. Cancer immune exclusion: breaking the barricade for a successful immunotherapy;Bruni;Front. Oncol.,2023
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Hypocrellin A against intrahepatic Cholangiocarcinoma via multi-target inhibition of the PI3K-AKT-mTOR, MAPK, and STAT3 signaling pathways;Phytomedicine;2024-12
2. A Graph Curvature-Based Pipeline for Discovering Immune Checkpoint Response Biomarkers;2024-09-08
3. Intestinal probiotic-based nanoparticles for cytotoxic siRNA delivery in immunotherapy against cancer;International Journal of Pharmaceutics;2024-09
4. Drug resistance and tumor immune microenvironment: An overview of current understandings (Review);International Journal of Oncology;2024-08-30
5. Inhibiting the Otub1/phosphorylated STAT3 axis for the treatment of non-small cell lung cancer;Acta Pharmacologica Sinica;2024-08-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3